AIM
PFE icon

Anchor Investment Management’s Pfizer PFE Stock Holding History

Anchor Investment Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.46M Sell
87,568
-2,667
-3% -$71K 0.21% 123
2025
Q4 		$2.25M Sell
90,235
-4,442
-5% -$112K 0.18% 125
2025
Q3 		$2.41M Sell
94,677
-14,475
-13% -$357K 0.2% 125
2025
Q2 		$2.65M Sell
109,152
-23,963
-18% -$559K 0.23% 114
2025
Q1 		$3.37M Sell
133,115
-5,349
-4% -$140K 0.31% 86
2024
Q4 		$3.67M Sell
138,464
-3,673
-3% -$99.6K 0.34% 77
2024
Q3 		$4.11M Sell
142,137
-1,166
-0.8% -$34K 0.39% 66
2024
Q2 		$4.01M Sell
143,303
-1,859
-1% -$51.2K 0.41% 63
2024
Q1 		$4.03M Sell
145,162
-3,626
-2% -$101K 0.42% 63
2023
Q4 		$4.28M Sell
148,788
-8,232
-5% -$249K 0.49% 54
2023
Q3 		$5.21M Sell
157,020
-3,204
-2% -$113K 0.68% 35
2023
Q2 		$5.88M Buy
160,224
+442
+0.3% +$17.2K 0.75% 32
2023
Q1 		$6.52M Sell
159,782
-1,968
-1% -$85K 0.89% 27
2022
Q4 		$8.29M Buy
161,750
+1,676
+1% +$80.4K 1.19% 16
2022
Q3 		$7M Buy
160,074
+2,846
+2% +$138K 1.09% 21
2022
Q2 		$8.24M Sell
157,228
-367
-0.2% -$18.7K 1.2% 18
2022
Q1 		$8.16M Sell
157,595
-919
-0.6% -$47.7K 1.03% 17
2021
Q4 		$9.36M Buy
158,514
+6,287
+4% +$311K 1.16% 16
2021
Q3 		$6.55M Buy
152,227
+3,791
+3% +$168K 0.91% 23
2021
Q2 		$5.81M Buy
148,436
+2,606
+2% +$101K 0.8% 30
2021
Q1 		$5.28M Buy
145,830
+12,831
+10% +$456K 0.8% 30
2020
Q4 		$4.9M Sell
132,999
-231
-0.2% -$8.47K 0.88% 24
2020
Q3 		$4.64M Buy
133,230
+2,300
+2% +$80.6K 0.94% 25
2020
Q2 		$4.06M Buy
130,930
+90
+0.1% +$3.06K 0.91% 25
2020
Q1 		$4.05M Buy
130,840
+7,156
+6% +$244K 1.05% 17
2019
Q4 		$4.6M Buy
123,684
+20,601
+20% +$734K 0.98% 20
2019
Q3 		$3.51M Buy
103,083
+2,478
+2% +$90.1K 0.81% 26
2019
Q2 		$4.13M Buy
100,605
+4,194
+4% +$167K 0.99% 19
2019
Q1 		$3.88M Sell
96,411
-573
-0.6% -$22.9K 0.97% 20
2018
Q4 		$4.02M Buy
96,984
+396
+0.4% +$16.4K 1.14% 15
2018
Q3 		$4.04M Sell
96,588
-947
-1% -$36.5K 0.92% 20
2018
Q2 		$3.36M Buy
97,535
+1,579
+2% +$54K 0.83% 23
2018
Q1 		$3.23M Buy
95,956
+3,142
+3% +$108K 0.85% 21
2017
Q4 		$3.19M Buy
92,814
+1,601
+2% +$54.6K 0.85% 24
2017
Q3 		$3.09M Buy
91,213
+1,741
+2% +$56K 0.91% 20
2017
Q2 		$2.85M Buy
89,472
+2,866
+3% +$90.4K 0.95% 21
2017
Q1 		$2.81M Buy
86,606
+2,709
+3% +$85.4K 0.97% 23
2016
Q4 		$2.59M Buy
83,897
+1,918
+2% +$58.6K 0.97% 24
2016
Q3 		$2.63M Buy
81,979
+299
+0.4% +$10K 1.02% 20
2016
Q2 		$2.73M Buy
81,680
+1,836
+2% +$58.6K 1.08% 17
2016
Q1 		$2.25M Buy
+79,844
New +$2.28M 0.92% 25

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Anchor Investment Management's PFE Position: Q1 2026 in Review

Anchor Investment Management reduced its Pfizer (PFE) stake by 3% in Q1 2026, selling an estimated $71K and leaving 87,568 shares worth $2.46M. The position accounts for 0.21% of the portfolio, ranked #123.

Anchor Investment Management first reported a position in PFE in Q1 2016 and has held it in 41 quarters since. The position peaked at $9.36M in Q4 2021. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Anchor Investment Management held 87,568 shares of Pfizer worth $2.46M as of Q1 2026.
  • Anchor Investment Management sold 2,667 Pfizer shares in Q1 2026, an estimated $71K.
  • Pfizer made up 0.21% of Anchor Investment Management's portfolio in Q1 2026, its #123 holding.
  • Anchor Investment Management first reported a position in Pfizer in Q1 2016 and has held it in 41 quarters since.
  • Anchor Investment Management's Pfizer position peaked at $9.36M in Q4 2021.
  • 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Anchor Investment Management's 13F filing for Q1 2026, filed 1 May 2026.